Orally disintegrating tablets (ODTs) are preferred for their convenience and speed. By providing fast-acting medication, ODTs allow manufacturers to add value to existing compounds and – important for competitive standing – extend product life cycles. With the ODT market growing at around 20% per year, the opportunities are considerable. Merck’s Parteck® ODT gives formulators the opportunity to produce top quality, rapid acting tablets more cost effectively than ever.
Benefits of Parteck® ODT: